IDH1 and central nervous system cancer: Among patients with lower-grade glioma, the T2/FLAIR-mismatch sign had a high specificity of 100% and 100% of PPV for detecting IDH-mutant (1p/19q non-codeleted) tumors, with a sensitivity of 10.9%, NPV of 3.0%, and accuracy of 13.3%.